Elotuzumab (anti-SLAMF7) (C007B-574671)

Elotuzumab is a humanized monoclonal antibody that binds human signaling lymphocytic activation molecule F7 (hSLAMF7, also known as CS1, CD319, or CRACC). Elotuzumab shows a dual mechanism of action that includes the direct activation of natural killer (NK) cells and the induction of NK cell–mediated antibody-dependent cellular cytotoxicity.Purity>95% (SDS-PAGE&SEC)Endotoxin Level<0.01EU/μg

Specifictaions: Carrier Free, Recombinant, ExactAb™, Azide Free, Validated, Animal Free, ≥95%(SDS-PAGE&SEC-HPLC), See COA

Related Documents: https://ald-pub-files.oss-cn-shanghai.aliyuncs.com/aladdinsci/pdp/sds/1/AB169272-SCI_875a2d2fbc5ef7a384f67dfb6761a449.pdf

UPC:

51202302

Condition:

New

Weight:

2.99 Ounces

HazmatClass:

No

Quantity:

1

Unit of Measurement:

EA

WeightUOM:

LB

MPN:

Ab169272-10mg

CAS:

915296-00-3

Product Size:

10mg